Exper Perspectives Logo
  • Home
  • Therapeutic Categories
    • BACK
    • Therapeutic Categories
    • Allergy & Immunology
      • BACK
      • Allergy & Immunology
      • Chronic Spontaneous Urticaria
      • Food Allergies
      • Pediatric Food Allergies
    • Dermatology
      • BACK
      • Dermatology
      • Atopic Dermatitis
      • Plaque Psoriasis
    • Endocrinology
      • BACK
      • Endocrinology
      • Type 2 Diabetes
    • Gastroenterology
      • BACK
      • Gastroenterology
      • Crohn's Disease
      • Ulcerative Colitis
    • Hematology
      • BACK
      • Hematology
      • Chronic Immune Thrombocytopenia
      • Paroxysmal Nocturnal Hemoglobinuria
      • Sickle Cell Disease
    • Hepatology
      • BACK
      • Hepatology
      • Liver Fibrosis
    • Infectious Diseases
      • BACK
      • Infectious Diseases
      • Adolescent Vaccinations
      • COVID-19 Prevention
      • Influenza
    • Nephrology
      • BACK
      • Nephrology
      • IgAN
      • IgAN & C3G
      • Renal Transplant Maintenance
    • Neurology
      • BACK
      • Neurology
      • Alzheimer's Disease
      • Epilepsy
      • Generalized Myasthenia Gravis
      • Insomnia
      • Migraine
      • Multiple Sclerosis
      • Relapsing Multiple Sclerosis
      • Spinal Muscular Atrophy
      • Tuberous Sclerosis Complex
    • Oncology
      • BACK
      • Oncology
      • Acute Myeloid Leukemia
      • Advanced Prostate Cancer
      • Advanced ROS1-positive NSCLC
      • Anemia in MDS
      • Carcinoid Syndrome
      • Chronic Graft-versus-Host Disease
      • Chronic Lymphocytic Leukemia
      • Chronic Myeloid Leukemia
      • Endometrial Cancer
      • Gastroenteropancreatic Neuroendocrine Tumors
      • Gastrointestinal Stromal Tumors
      • HER2+ Breast Cancer
      • HR+ HER2- Breast Cancer
      • HR+ HER2- Early Breast Cancer
      • Locally Advanced Basal Cell Carcinoma
      • Mantle Cell Lymphoma
      • Melanoma
      • Metastatic Breast Cancer
      • Metastatic Pancreatic Cancer
      • Multiple Myeloma
      • Myelofibrosis
      • Myeloproliferative Neoplasms
      • Non-Small Cell Lung Cancer
      • Prostate Cancer
      • PSMA+ mCRPC
      • Relapsed/Refractory Diffuse Large B-Cell Lymphoma
      • Relapsed/Refractory Multiple Myeloma
    • Ophthalmology
      • BACK
      • Ophthalmology
      • Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
      • Wet AMD
    • Osteoporosis
      • BACK
      • Osteoporosis
      • Osteoporosis
    • Psychiatry
      • BACK
      • Psychiatry
      • Major Depressive Disorder
      • Schizophrenia
      • Tardive Dyskinesia
    • Pulmonology
      • BACK
      • Pulmonology
      • Asthma
      • COPD
      • Interstitial Lung Disease
    • Rheumatology
      • BACK
      • Rheumatology
      • Psoriatic Arthritis
      • Rheumatoid Arthritis
      • Systemic Lupus Erythematosus
    • Urology
      • BACK
      • Urology
      • Uncomplicated Urinary Tract Infections
  • Conference Reporter
  • Expert Directory
  • About Expert Perspectives
  • Login/Register

experspadmin

Chronic Lymphocytic Leukemia: Mechanisms of Resistance to Treatment
Oncology

Chronic Lymphocytic Leukemia: Mechanisms of Resistance to Treatment

clinical topic updates
By Matthew S. Davids, MD, MMSc
Exploring the Next-Generation Small-Molecule Inhibitors for Chronic Lymphocytic Leukemia
Oncology

Exploring the Next-Generation Small-Molecule Inhibitors for Chronic Lymphocytic Leukemia

clinical topic updates
By William G. Wierda, MD, PhD
The Role of Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia
Oncology

The Role of Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Chronic Lymphocytic Leukemia

patient care perspectives
By William G. Wierda, MD, PhD
Reducing Toxicity From Chronic Lymphocytic Leukemia Treatment
Oncology

Reducing Toxicity From Chronic Lymphocytic Leukemia Treatment

patient care perspectives
Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Mantle Cell Lymphoma
Oncology

Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Mantle Cell Lymphoma

expert roundtables
By Anita Kumar, MD; Daniel O. Persky, MD; Julie M. Vose, MD, MBA, FASCO
Load More   
logo 2026 Expert Perspectives®
Privacy Policy     Terms of Service     About Expert Perspectives

Your California Privacy Rights     Do Not Sell My Personal Information
Login Expert Perspectives
Forgot Password?
or Create an Account
Create an Account
Forgot Password?